Risks and benefits of hormone replacement therapy in older men.

The use of testosterone in older men, known as male hormonal replacement therapy or androgen replacement therapy, has become of increasing interest to both the medical and lay communities over the past decade. Even though the knowledge of the potential benefits and risks of male Androgen Replacement Therapy has increased dramatically, there is still much that needs to be determined. Although there are a number of potential benefits of male Androgen Replacement Therapy and data concerning clinical effects of such replacement have accumulated, as yet there have not been any large multicenter randomized controlled trials of this therapy. It is the purpose of this article to review what is currently known about the possible risks and benefits of male Androgen Replacement Therapy by discussing the clinical trials to date.

[1]  W. Hellstrom,et al.  Androgen deficiency in the aging male: Pathophysiology, diagnosis, and treatment alternatives , 2001, Current urology reports.

[2]  R. Mcclure,et al.  Androgen deficiency and the aging male: New urologic perspectives , 2001, Current urology reports.

[3]  A. C. Bonaccorsi Andropausa: insuficiência androgênica parcial do homem idoso. Uma revisão , 2001 .

[4]  E. Metter,et al.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. , 2001, The Journal of clinical endocrinology and metabolism.

[5]  A. Iranmanesh,et al.  Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. , 2000, The Journal of clinical endocrinology and metabolism.

[6]  C. Carson,et al.  Andropause: a misnomer for a true clinical entity. , 2000, The Journal of urology.

[7]  F. Hayes Testosterone--fountain of youth or drug of abuse? , 2000, The Journal of clinical endocrinology and metabolism.

[8]  A. Iranmanesh,et al.  Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. , 2000, The Journal of clinical endocrinology and metabolism.

[9]  M. Godschalk,et al.  Testosterone Improves Rehabilitation Outcomes in Ill Older Men , 2000, Journal of the American Geriatrics Society.

[10]  E. Nieschlag,et al.  Hormone substitution in male hypogonadism , 2000, Molecular and Cellular Endocrinology.

[11]  C. Mantzoros,et al.  Hormonal predictors of prostate cancer: a meta-analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Hayward,et al.  Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. , 1999, Circulation.

[13]  M. Horan,et al.  Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men. , 1999, International journal of andrology.

[14]  J. Berlin,et al.  Effect of testosterone treatment on bone mineral density in men over 65 years of age. , 1999, The Journal of clinical endocrinology and metabolism.

[15]  E. Barrett-Connor,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Bioavailable Testosterone and Depressed Mood in Older Men: The Rancho Bernardo Study , 2022 .

[16]  C. Webb,et al.  Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. , 1999, The American journal of cardiology.

[17]  M. Armitage,et al.  Experience with transdermal testosterone replacement therapy for hypogonadal men , 1999, Clinical endocrinology.

[18]  J. Tenover,et al.  Male hormone replacement therapy including "andropause". , 1998, Endocrinology and metabolism clinics of North America.

[19]  M. Rabijewski,et al.  [The influence of testosterone replacement therapy on well-being, bone mineral density and lipids in elderly men]. , 1998, Polskie Archiwum Medycyny Wewnetrznej.

[20]  D. Jorkasky,et al.  Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapy. , 1998, Clinical therapeutics.

[21]  J. Morley,et al.  Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. , 1997, The Journal of clinical endocrinology and metabolism.

[22]  T. Link,et al.  Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. , 1997, The Journal of clinical endocrinology and metabolism.

[23]  H. Perry,et al.  Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. , 1997, The Journal of clinical endocrinology and metabolism.

[24]  R. Casaburi,et al.  Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. , 1997, The Journal of clinical endocrinology and metabolism.

[25]  D. Schoenfeld,et al.  Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. , 1996, The Journal of clinical endocrinology and metabolism.

[26]  R. Swerdloff,et al.  Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[27]  N. Ancy,et al.  The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. , 1996 .

[28]  I. Reid,et al.  Testosterone therapy in glucocorticoid-treated men. , 1996 .

[29]  R. Wolfe,et al.  Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. , 1995, The American journal of physiology.

[30]  D. Rudman,et al.  Polycythemia as a Complication of Testosterone Replacement Therapy in Nursing Home Men with Low Testosterone Levels , 1995, Journal of the American Geriatrics Society.

[31]  G. B. Phillips,et al.  The association of hypotestosteronemia with coronary artery disease in men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  E. Nieschlag,et al.  Lifespan and testosterone , 1993, Nature.

[33]  L. Sjöström,et al.  Androgen treatment of abdominally obese men. , 1993, Obesity research.

[34]  Y. Weisman,et al.  Decreased bone density in elderly men treated with the gonadotropin-releasing hormone agonist decapeptyl (D-Trp6-GnRH). , 1993, The Journal of clinical endocrinology and metabolism.

[35]  H. Perry,et al.  Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study , 1993, Journal of the American Geriatrics Society.

[36]  J. S. Tenover Effects of testosterone supplementation in the aging male. , 1992, The Journal of clinical endocrinology and metabolism.

[37]  M. Riggs,et al.  Testosterone Deficiency As a Risk Factor for Hip Fractures in Men: A Case‐Control Study , 1992, The American journal of the medical sciences.

[38]  L. Lantinga,et al.  Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence. , 1991, The Journal of urology.

[39]  R. Poses,et al.  Does Hypogonadism Contribute to the Occurrence of a Minimal Trauma Hip Fracture in Elderly Men? , 1991, Journal of the American Geriatrics Society.

[40]  A. Vermeulen Clinical review 24: Androgens in the aging male. , 1991, The Journal of clinical endocrinology and metabolism.

[41]  D. Baylink,et al.  Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. , 1989, The Journal of clinical endocrinology and metabolism.

[42]  J. Fleetham,et al.  REVERSIBLE REPRODUCTIVE DYSFUNCTION IN MEN WITH OBSTRUCTIVE SLEEP APNOEA , 1988, Clinical endocrinology.

[43]  Kathryn A. Lee,et al.  TESTOSTERONE REPLACEMENT IN HYPOGONADAL MEN: EFFECTS ON OBSTRUCTIVE SLEEP APNOEA, RESPIRATORY DRIVES, AND SLEEP , 1985, Clinical endocrinology.

[44]  N. Skakkebaek,et al.  ANDROGEN REPLACEMENT WITH ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MEN: A DOUBLE BLIND CONTROLLED STUDY , 1981, Clinical endocrinology.

[45]  H. Behre The Aging Male , 2002 .

[46]  G. Cunningham The Aging Male , 2002 .

[47]  D. Crook,et al.  Androgens and the risk of cardiovascular disease. , 2000 .

[48]  J. Tenover Experience with testosterone replacement in the elderly. , 2000, Mayo Clinic proceedings.

[49]  T. Link,et al.  Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. , 1998, European journal of endocrinology.

[50]  J. Mckinlay,et al.  An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. , 1991, Journal of clinical epidemiology.